A prospective study to assess the efficacy and safety of iron sucrose in pregnant women with iron deficiency anemia in a tertiary care hospital

Authors

  • R. Nanthini Department of Pharmacology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India
  • K. R. Mamatha Department of Pharmacology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India
  • Geetha Shivamurthy Professor, Department of Obstetrics and Gynaecology, Bangalore Medical College and Research Institute Affiliated to Rajiv Gandhi University of Health Science, Karnataka, India
  • R. Kavitha Department of Pharmacology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20151371

Keywords:

Hematological parameters, Iron deficiency anemia, Iron sucrose, Pregnant women

Abstract

Background: Prevalence of iron deficiency anemia (IDA) is 58% among pregnant women in India. Oral iron therapy is recommended as first-line therapy in mild anemia. Moderate anemia in pregnancy results in high maternal morbidity and mortality. In India, women become pregnant with low iron stores, where oral iron therapy cannot meet the requirement and need parenteral iron therapy. This study was undertaken to evaluate the efficacy and safety of iron sucrose complex (ISC) in pregnant women with IDA.

Methods: A prospective study was conducted between June 2014 and June 2015 in the Department of Obstetrics and Gynaecology, Bangalore medical college and research institute. 60 pregnant women having hemoglobin (Hb) between 7 and 9 g/dl with diagnosed IDA were given intravenous ISC in a dose of 200 mg on alternate days after calculating the dose requirement. The efficacy of the therapy was assessed by hematological parameters measured at 4 weeks and 8 weeks of treatment. To assess the safety, adverse drug effects were recorded.

Results: The mean Hb increased from 8.02±0.56 to 11.38±0.5 g% (p<0.0001) after eight weeks of therapy. There was a significant rise in serum ferritin levels (from 15.12±1.8 to 31.4±4.9 µg/l) (p<0.0001) at the end of the study. Other parameters including mean corpuscular volume, mean corpuscular Hb, mean corpuscular Hb concentration, and serum reticulocyte count were also improved significantly. There were no allergic reactions.

Conclusion: Parenteral iron therapy was effective in increasing Hb, serum ferritin, and other hematological parameters in pregnant women with moderate anemia. Intravenous iron sucrose complex can be used in tertiary care hospitals where it can replace conventional parenteral iron therapy due to injection-related side effects.

References

Planning Commission. Government of India. Tenth Five-Year Plan, 2002-2007. Sectoral Policies and Programmes. Nutrition. New Delhi: Government of India; 2002. Available at http://www.lanningcommission.nic.in/plans/planrel/fiveryr/

th/10defaultchap.html. Accessed 12 December 2012.

Toteja GS, Singh P. Micronutrient Profile of Indian Population. New Delhi: Indian Council of Medical Research; 2004.

Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol. 2002;186(3):518-22.

Kalaivani K. Prevalence and consequences of anaemia in pregnancy. Indian J Med Res. 2009;130(5):627-33.

Worldwide Prevalence of Anaemia 1993–2005. WHO Global Database on Anaemia. Geneva: World Health Organization; 2008.

Silverstein SB, Rodgers GM. Parenteral iron therapy options. Am J Hematol. 2004;76(1):74-8.

Charytan C, Levin N, Al-Saloum M, Hafeez T, Gagnon S, Van Wyck DB. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. Am J Kidney Dis. 2001;37(2):300-7.

Adamson J. Iron deficiency anaemia and other hypoproliferative anaemias. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al., editors. Harrison’s Principles of Internal Medicine. 18th Edition. New York: McGraw Hill Medical Publications; 2012: 844 51.

Gupta U, Srivastava K, Dubry A, Arif A, Gupta NK. Efficacy and safety of intravenous iron sucrose for treating anaemia in pregnancy: a pilot study. J Evol Med Dent Sci. 2013;2(27):5007-13.

Gupta K, Arnold F, Kishor S, Parasuraman S. Concern on prevalence of anaemia in pregnant and lactating women in India. Indian J Med Res. 2007;125(1):99-101; author reply 101.

Rabeya A, Hasina A. Use of iron sucrose complex in treatment of anemia in pregnancy. Bangladesh J Obstet Gynaecol. 2010;25(1):20-3.

Mother’s Mean Age at First Birth. Available at http://www.cia.gov/library/publications/the­world­factbook/fields/2256. Accessed 29 September 2015.

Rosmawati NH, Nazri SM, Ismail IM. The rate and risk factors for anemia among pregnant mothers in Jerteh Terengganu, Malaysia. J Community Med Health Educ. 2012;2:5.

Lelissa D, Yilma M, Shewalem W, Abraha A, Worku M, Ambachew H, et al. Prevalence of Anemia among women receiving antenatal care at Boditii Health Center, Southern Ethiopia. Clin Med Res. 2015;4(3):79-86.

Milman N. Iron prophylaxis in pregnancy - general or individual and in which dose? Ann Hematol. 2006;85:821-8.

Milman N, Bergholt T, Eriksen L, Byg KE, Graudal N, Pedersen P, et al. Iron prophylaxis during pregnancy -- how much iron is needed? A randomized dose- response study of 20-80 mg ferrous iron daily in pregnant women. Acta Obstet Gynecol Scand. 2005;84(3):238-47.

Perewusnyk G, Huch R, Huch A, Breymann C. Parenteral iron therapy in obstetrics: 8 years-experience with iron-sucrose complex. Br J Nutr. 2002;88:3-10.

Wali A, Mushtaq A, Nilofer. Comparative study – Efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. J Pak Med Assoc. 2002;52(9):392-5.

Kriplani A, Mahey R, Dash BB, Kulshreshta V, Agarwal N, Bhatla N. Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. Indian J Med Res. 2013;138:78 82.

al-Momen AK, al-Meshari A, al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;69(2):121 4.

Raja K, Janjua NB, Khokhar N. Intravenous iron sucrose therapy in iron deficiency anemia in pregnancy. J Pak Med Assoc. 2003;28(2):40-3.

Shabbir K, Batool N, Khokhar N. Intravenous iron sucrose complex therapy in iron deficiency anaemia in the pregnant women. Rawal Med J. 2003;28:1-10.

Prasanna B, Naimisha M, Jhansi CB, Shaik MV. Safety and efficacy of high dose intravenous iron sucrose for treating anaemia in pregnancy. Sch J Appl Med Sci. 2014;2(2B):623 7.

Breymann C. The use of iron sucrose complex for anemia in pregnancy and postpartum period. Semin Hematol. 2006;43:28-31.

Megha S, Akshay C, Bhadresh J, Kamlesh M. Intravenous iron sucrose therapy in pregnant and postpartum patients. Gujarat Med. J. 2012;67(1):57-60.

Downloads

Published

2017-01-16

How to Cite

Nanthini, R., Mamatha, K. R., Shivamurthy, G., & Kavitha, R. (2017). A prospective study to assess the efficacy and safety of iron sucrose in pregnant women with iron deficiency anemia in a tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 4(6), 1271–1275. https://doi.org/10.18203/2319-2003.ijbcp20151371

Issue

Section

Original Research Articles